Skip to search formSkip to main contentSkip to account menu

clomacran

Known as: 2-chloro-9-(3-dimethylaminopropyl)acridan, 9-acridinepropanamine, 2-chloro-9,10-dihydro-N,N-dimethyl- 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Acridines

Narrower (1)

SK&F 14,336
clomacran phosphate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Clozapine and Several Other Antipsychotic/Antidepressant Drugs Preferentially Block the Same ‘Core’ Fraction of GABAA Receptors
Clozapine and several other antipsychotic/antidepressant drugs that fully or partially block GABAA receptors were tested at… 
1977
1977
Pharmacological evaluation of clomacran, a new potent psychotropic agent.
1977
1977
A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients.
1975
1975
Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods.
In an uncontrolled clinical trial clomacran, the chlorpromazine analogue of the acridane series, was found to be therapeutically… 
1974
1974
A transcultural study with clomacran: comparison of two assessment methods.
1972
1972
Clomacran in anxious neurotic outpatients: a controlled study.
1971
1971
Clomacran and chlorpromazine in psychotic outpatients: a controlled study.
1970
1970
Adverse effects with clomacran.
1969
1969
A double blind study of clomacran.
1969
1969
A double blind study of clomacran.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)